Transarterial chemoembolization (TACE) with Irinotecan and Mitomycin C versus TACE with Doxorubicin in patients with Hepatocellular carcinoma not amenable to curative treatment - IRITACE- a randomized multicenter phase 2 trial. A trial of the German Alliance for Liver Cancer (GALC). (IRITACE)

Irinotecan + Mitomycin C, Doxorubicin

Status: In Rekrutierung

Klinische Settings

Beteiligte

Identifier

Links

Kontakt